| Hosting Organization |
 |
 |
| Operating Organization |
Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision
BIT Lifesciences, Inc. |
| Supporting Organization |
 |
| International Marketing Partner |
 |
|
Participants List
(Academia) |
National Yang-Ming University, Taiwan
Abyad Medical Center and Middle-East Longevity Institute, Lebanon
Akershus University Hospital, Norway
Aligarh M University, India
American University of Beirut, USA
Antwerp University Hospital, Belgium
Applied Proteomics and Molecular Medicine, USA
Aristotelian University of Thessaloniki, Greece
Banaras Hindu University, India
Barrow Neurological Institute, USA
Baylor College of Medicine, USA
Ben-Gurion University of the Negev, Israel
Boston University School of Medicine, USA
Cancer Research Technology, UK
CHDI Foundation, California
Chinese Academy of Sciences, China
CRG-Centre de Regulaci Genmica, Spain
CSIRO Molecular and Health Technologies, Australia
Duke University, USA
Emory University, USA
exas Southern University, USA
Florida A&M University, USA
Global Pathology Support, The Netherlands
Gujarat AIDS Awareness and Prevention Unit, India
Haematopoietic Stem Cell Laboratory, UK
Harvard Medical School, USA
Hospital S Hospital S Joao, Portugal
Human BioMolecular Re-. search Institute, USA
Indiana University School of Medicine, USA
Indiana University School of Medicine, USA
Innsbruck Medical University, Austria
Institute of Experimental Pharmacology, Slovak
Instituto De Biologia Experimentale Tecnologica, Portugal
Karolinska Institutet, Sweden
Keystone College Academia, USA
McGill University, Canada
Mercer University, USA
National Center for Toxicological Research, USA
National Institutes of Health, USA
Netherlands Cancer Institute, The Netherlands
New York Medical College, USA
Osaka University, Japan
Paul-Ehrlich-Institute, Germany
Penn State College of Medicine, USA
Pennsylvania State University College of Medicine, USA
Pharmacology Temple University, USA
Scientific Advisory Board Tolerx, USA
Shanghai Unviversity of Traditional Chinese Medicine, China
Solid Tumor Working Party, Italy
Stanford University, USA
Structural Genomics Consortium Karolinska Institutet, Sweden
Tabriz University of Medical Sciences, Iran
Technion - Israel Institute of Technology Rappaport Institute, Israel
The Babraham Institute, UK
The Hebrew University, Israel
The Institute of Cancer Research, UK
The University of Queensland, Australia
The University of Sydney, Australia
The University of Texas, USA
UC College of Medicine, USA
Universidade Federal Fluminense, Brazil
University Clinic Bonn, Germany
University of Basel, Switzerland
University of British Columbia, Canada
University of California, USA
University of California-San Francisco, USA
University of Camerino, Italy
University of Cape Town, USA
University of Colorado Health Sciences Center, USA
University of Crete, Greece
University of Geneva, Switzerland
University of Heidelberg, Germany
University of Hong Kong, China
University of Maryland School of Pharmacy, USA
University of Maryland, USA
University of Massachusetts Medical School, USA
University of Miami School of Medicine, USA
University of Miami, USA
University of Miami, USA
University of Oklahoma Health Sciences Center, USA
University of Siena, Italy
University of Southern Denmark, Denmark
University of Texas at Dallas, USA
University of Texas Health Science Center, USA
University of Texas Medical, USA
University of the Sciences in Philadelphia, USA
University of Utah School of Medicine, USA
University of Western Australia, Australia
Utah State University, USA
Virginia Commonwealth University, USA
University of Gothenburg, Sweden
|
Participants List
(Business) |
3 P Biopharmaceuticals, USA
Abbott Laboratories, USA
Adolor Corporation, USA
Affimed Therapeutics AG, Germany
AILERON Therapeutics, USA
Algorithme Pharma Inc., Canada
Allon Therapeutics Inc., USA
Alpha Cancer Technologies Inc., USA
Alpha-2 Pharmaceutica AB, Israel
Amgen, Inc., USA
Arena Pharmaceuticals, USA
Astellas Pharma Inc, Japan
Astellas Pharmaceutical Inc., Japan
AstraZeneca Pharmaceuticals, USA
AstraZeneca R&D Molndal, Sweden
Astrazeneca R&D Sodertolje, Sweden
AstraZeneca, UK
AstraZeneca, USA
AuxoCell Laboratories, Inc., USA
Avexa Ltd, Australia
Bayer HealthCare, USA
Bayer Schering Pharma AG, Germany
BellBrook Labs, LLC, USA
Biological Mimetics, Inc., USA
BioPerspectives, USA
Biota Holdings Limited, USA
Boehringer Ingelheim Pharmaceuticals, Inc., USA
Bristol-Myers Squibbs, USA
Centocor/Johnson & Johnson, USA
Chemistry Forma Therapeutics, Inc., Singapore
Coley Pharmaceutical GmbH, Germany
Cordex Pharma, Inc., USA
Cornerstone Pharmaceuticals, USA
Covidien, USA
Daiichi Sankyo Pharma Development, Japan
deCODE Chemistry, USA
DxS Ltd, USA
Eisai Co., Ltd., Japan
Elan Pharmaceuticals, USA
Europe GlaxoSmithKline R&D, UK
Genentech, USA
Genetix Ltd, UK
genscript, USA
Genzyme Pharmaceuticals, USA
Gilead Sciences Benzothiadiazine Hepatitis C NS5B, USA
Hoffmann-La Roche, Switzerland
ICON PLC, USA
IDDC Corporation, USA
Idera Pharmaceuticals, USA
Jesus College, England
Johnson & Johnson Pharmaceutical, USA
Johnson & Johnson Research Pty Limited, Australia
Laboratory Cellular Technology Ltd., USA
Lundbeck Research, USA
Mallinckrodt, Inc., USA
MDS Pharma Services, USA
Medimmune, UK
Merck & Co. Inc, USA
Merck & Co., Italy
Merck and Co., Inc., China
Merck KGaA, Germany
Merck Research Laboratories, USA
Nerviano Medical Sciences, Italy
Novartis Institutes for Biomedical Research, USA
Novartis Institutes, Switzerland
Novartis Pharmaceuticals Corporation, USA
Novartis, China
Ocimum Biosolutions, India
Ondokuz Mayis University, Turkey
OphthalmoPharma, Switzerland
Pfizer, USA
Pharmanet Development Group, Inc., USA
PharmaNet, Inc., USA
Ranbaxy Laboratories Limited, India
Reaction Biology Corporation, USA
RegPak BioPharma Consulting, The Netherlands
Sanofi Aventis, USA
Schering Plough Research Institute, USA
Schlich & Co, UK
Scott & White, USA
Sequoia Pharmaceuticals Inc., USA
SeraCare Life Sciences, USA
Shanghai Biochip Co., Ltd, China
Shenogen Pharma Group, China
Siena Biotech S.p.A. A company, USA
Simulations Plus, Inc., USA
Synta Pharmaceuticals Corp, USA
TEVA Pharmaceuticals, USA
The Takeda Oncology Company, USA
ThromboGenics, USA
Transgene, France
US Oncology Research, Inc., USA
Vaxinnate, USA
Wyeth Research, USA
XOMA (US) LLC, USA
Zeptosens C a Division of Bayer (Schweiz) AG, Switzerland
Zhejiang Hisun Pharmaceutical Co., Ltd, China
Tehran University of Medical Sciences , Iran
|
|
 |
|
 |
WCG 2009
(December 1-7, 2009, Foshan, China) |
 |
ICC 2009
(Dec. 5-7, 2009, Shanghai, China) |
 |
ICA 2010
(March 24-26, 2010, Beijing, China) |
 |
WCV 2010
(March 24-26, 2010, Beijing, China) |
 |
SEB 2010
(Apr. 22-24, 2010, Shanghai, China) |
|
|
|
| Why Speak? |
|
We are on the lookout for leaders and experts both from industry and academia to speak at IDDST- 2009.
Over the past several years, our highly successful Life Science events have attracted international speakers from top pharmaceutical and biotech companies, universities and research institutions. Focusing on quality content and bringing in only top-level speakers, our events have strongly established themselves as THE life science leading events to attend worldwide and have built a solid reputation as one of the most informative technical conferences. Below are just a few more reasons why you should be a speaker at this year's Conference:
• Meet the researchers across disciplines and disease sites face-to-face;
• Network and exchange ideas with other experts;
• Work with an intimate and targeted audience;
• Raise your profile as a professional in the Drug Discovery field;
• Use this opportunity to influence the realm through your ideas and perspectives;
• In addition your name will be on all brochures distributed to over 10,000 scientists worldwide;
• have the unique opportunity to seal your corporate and academic presence;
• build up your comprehensive network.
Speakers are carefully selected to represent a diversity of experience, personalities, ideologies, and viewpoints. These speakers will be renowned experts who have demonstrated outstanding thought, influenced innovation achieved success in their Drug Discovery efforts. If you would like to submit a proposal to give a presentation or display a poster at this congress, please send us an abstract and brief us a 3-5sentence summary of a proposed topic on your recent work in the area of Drug Discovery
Speaker roles
What sort of speakers are there and what are their roles?
Keynotes
Keynote speakers present the first session or key session at the conference and receive the highest billing in all event marketing. Their role is to open the conference with a high-level speech that sets the tone for the whole event.
Chairmen
A chairman's role is to make a few opening remarks at the start of the sessions and symposium, introduce each speaker, field questions from the audience (asking a couple of his/her own if there are none from the floor) and keep everything to time. Chairman will be asked to make announcements to delegates and they remain on/near the stage throughout the day.
Session speaker
Individual speakers are required to prepare a 20 – 25 minute presentation, with slides. They will be introduced by the chairman and then allowed to speak, free of interruption, for the allocated time slot, allowing for 5-10 minutes of questions from the audience at the end (which the chairman will facilitate).
Panelists
Panel speakers are not required to provide powerpoint slides for their session. But they can provide papers for delegates' reading, which will be inserted into the conference proceedings. They will be introduced by the panel moderator and asked a few questions. They will then be involved in a debate/interactive discussion with the moderator, the other panel members and the audience.
Moderator
Panel moderators are required to introduce each panelist and ask them a series of pre-prepared questions in a “chat show host” style. They also need to encourage audience participation, fielding questions from the floor, whilst keeping the whole panel to allocated time.
Sponsor
Sponsor speakers are either session speakers or panelists. They are encouraged to keep to the topic suggested to them by the conference organizer and not to lapse into sales pitches! This is to help sustain attention from the audience.
Note:
No team presentations are allowed.
Except for "keynote" speakers who we will contact directly, travel and hotel arrangements as well as the registration fee will be the responsibility of the speaker. The Organizing Committee will not cover travel, hotel expenses. |
|
|
About IDDST
